PTGFR
Basic information
Region (hg38): 1:78303884-78540701
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTGFR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 1 | 2 |
Variants in PTGFR
This is a list of pathogenic ClinVar variants found in the PTGFR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-78492766-A-T | Benign (Aug 07, 2018) | |||
1-78492772-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
1-78492811-A-G | not specified | Uncertain significance (Nov 18, 2023) | ||
1-78492878-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
1-78493020-G-A | not specified | Uncertain significance (May 14, 2024) | ||
1-78493042-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
1-78493140-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
1-78493185-A-G | not specified | Uncertain significance (Dec 20, 2021) | ||
1-78493192-A-T | Myoepithelial tumor | Uncertain significance (Nov 01, 2022) | ||
1-78493247-G-T | not specified | Uncertain significance (Aug 22, 2023) | ||
1-78493354-T-A | not specified | Uncertain significance (Jun 24, 2022) | ||
1-78493396-T-C | Benign (Mar 29, 2018) | |||
1-78493420-C-G | not specified | Uncertain significance (Oct 30, 2023) | ||
1-78493461-G-A | not specified | Uncertain significance (May 02, 2024) | ||
1-78536619-A-G | Likely benign (Jul 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTGFR | protein_coding | protein_coding | ENST00000370757 | 2 | 235867 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0661 | 0.921 | 125723 | 0 | 23 | 125746 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.17 | 149 | 195 | 0.765 | 0.00000977 | 2349 |
Missense in Polyphen | 40 | 72.712 | 0.55011 | 899 | ||
Synonymous | 0.0459 | 71 | 71.5 | 0.993 | 0.00000372 | 721 |
Loss of Function | 2.17 | 4 | 12.1 | 0.329 | 7.63e-7 | 136 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for prostaglandin F2-alpha (PGF2-alpha). The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. Initiates luteolysis in the corpus luteum (By similarity). Isoforms 2 to 7 do not bind PGF2-alpha but are proposed to modulate signaling by participating in variant receptor complexes; heterodimers between isoform 1 and isoform 5 are proposed to be a receptor for prostamides including the synthetic analog bimatoprost. {ECO:0000250, ECO:0000269|PubMed:18587449}.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;GPCRs, Other;Small Ligand GPCRs;GPCRs, Class A Rhodopsin-like;Prostaglandin Synthesis and Regulation;Signaling by GPCR;Signal Transduction;eicosanoid metabolism;Prostanoid ligand receptors;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- loftool
- 0.414
- rvis_EVS
- 0.28
- rvis_percentile_EVS
- 71.41
Haploinsufficiency Scores
- pHI
- 0.367
- hipred
- Y
- hipred_score
- 0.695
- ghis
- 0.465
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.227
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptgfr
- Phenotype
- endocrine/exocrine gland phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- inflammatory response;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;parturition;positive regulation of cell population proliferation;positive regulation of gene expression;response to estradiol;response to lipopolysaccharide;calcium-mediated signaling using intracellular calcium source;negative regulation of apoptotic process;cellular response to prostaglandin D stimulus
- Cellular component
- extracellular region;cytoplasm;plasma membrane;integral component of plasma membrane
- Molecular function
- prostaglandin F receptor activity